Cognition
is a New York-based biopharmaceutical company that researches and develops small molecule therapeutics for the treatment of neurodegenerative diseases... Read moreCognition
is a New York-based biopharmaceutical company that researches and develops small molecule therapeutics for the treatment of neurodegenerative diseases... Read more
2007
PublicIndependent CompanyNASDAQCGTX
News
Apr 01, 2025
Benzinga
Cognition: Cognition Therapeutics Presents Results at AD/PD 2025 Showing Impact of Zervimesine (CT1812) on Alzheimer's Disease Processes
Mar 25, 2025
FinanzNachrichten
Cognition: Cognito Therapeutics to Present New Data on Spectris' Impact on Brain Structure in Alzheimer's Disease at AD/PD 2025
Mar 21, 2025
Owler
Cognition Therapeutics, Inc.: Cognition's employee count had no change from Mar 2024 to Mar 2025
Mar 20, 2025
Seeking Alpha
Cognition: Cognition Therapeutics GAAP EPS of -$0.86
Mar 20, 2025
Seeking Alpha
Cognition: Cognition Therapeutics, Inc (CGTX) Q4 2024 Earnings Call Transcript
Mar 13, 2025
Benzinga
Cognition: Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results
Mar 12, 2025
centralcharts
Press Release: Cognition : Cognition Therapeutics Granted Extension to Meet Nasdaq Minimum Bid Price Requirement for Continued Exchange Listing
Feb 06, 2025
citybuzz
Cognition: Promising Drug Zervimesine Shows Potential in Treating Dementia with Lewy Bodies
Jan 13, 2025
citybuzz
Cognition: Cognition Therapeutics Advances Promising Drug for Dementia with Lewy Bodies to Phase 3 Trials
Jan 08, 2025
Benzinga
Cognition: Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences
Cognition Competitors
1
2
3
4
5
6
7
8
9